Comparative study of centesimal and millesimal potency in treatment of allergic rhinitis

Phase 4

Not yet recruiting

Conditions: Allergic rhinitis, unspecified,

Registration Number: CTRI/2022/05/042495

Lead Sponsor: Vinayaka Missions homoeopathic medical college and Hospital

Brief Summary: Allergic rhinitis is a very common disorder that affects up to 40% of the population. Allergic rhinitis is the most common type of chronic rhinitis, affecting 10 to 20% of the population,

and evidence suggests that the prevalence of the disorder is increasing. Severe allergic rhinitis has been associated with significant impairments in quality of life, sleep and work performance. According toWHO (2007), the global burden of allergic rhinitis was estimated to be 400 million and the prevalence among adult ranges between 10% and 32% in Asia Pacific region.

There are many researches conducted in the past to analyze the effectiveness of Homoeopathy in the treatment of Allergic Rhinitis, and was found that homoeopathic treatment is very much effective in treating allergic rhinitis. There by it improves the quality of life of patients. But mostly studies were done with specific remedies. So, this study is been taken to analyze the effectiveness of Millesimal and Centesimal potencies in the treatment of Allergic Rhinitis.

Hahnemannâ€™s initial objective for working on the sixth edition of Organon of Medicine was his awareness of the ill effects caused by frequently repeated but not modified homoeopathic doses. He felt that the aggravations caused by centesimal potency increases the sufferings of the patient. Later from his

practice Hahnemann understood that, by administering liquid doses altered by succussions produces slight change

in potency and that this improves the therapeutic effect with less side effects. So, he introduced the concept of 50 millesimal potency or LM scale. In this potency, the strength of the medicine can be slightly increased every time by succussions. And the repetition and elevation in potency will not produce any aggravation or new unwanted symptoms in the patient.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

patients selected from age 10 to 60 and patients with clinical presentation of allergic rhinitis.

Exclusion Criteria

cases with complications of allergic rhinitis and patients suffering from other systemic diseases and pregnant ladies will not be considered for the studies.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Absolute Eosinophil Count	after 6 months
Serum IgE level	after 6 months

Secondary Outcome Measures

Name	Time	Method
it is expected that the proposed study will be useful in reducing the symptoms of Allergic Rhinitis and to improve the quality of life of the patients	after 6 months

Trial Locations

Locations (1): vinayaka missions homoeopathic medical college
🇮🇳
Salem, TAMIL NADU, India
vinayaka missions homoeopathic medical college
🇮🇳Salem, TAMIL NADU, India
Dr E Nisha Paul
Principal investigator
9995680275
Nisha.gopal2012@gmail.com